What does DOKTER FRANCESKA DEDEURWAERDERE do?

DOKTER FRANCESKA DEDEURWAERDERE is a healthcare practice in Ingelmunster. Private Limited, started on 23 July 2002, 1 establishment.

What is the address of DOKTER FRANCESKA DEDEURWAERDERE?

The registered office of DOKTER FRANCESKA DEDEURWAERDERE is located at Bruggestraat 74 box B, 8770 Ingelmunster.

Is DOKTER FRANCESKA DEDEURWAERDERE still active?

Yes. According to the CBE (20 September 2026) DOKTER FRANCESKA DEDEURWAERDERE is active, legal situation “Normale toestand”, started on 23 July 2002.

Is DOKTER FRANCESKA DEDEURWAERDERE registered on Peppol?

Yes, DOKTER FRANCESKA DEDEURWAERDERE is registered on the Peppol network with ID 0208:0477979673.

What is the enterprise number of DOKTER FRANCESKA DEDEURWAERDERE?

The enterprise number of DOKTER FRANCESKA DEDEURWAERDERE is BE0477979673.

When was DOKTER FRANCESKA DEDEURWAERDERE founded?

DOKTER FRANCESKA DEDEURWAERDERE was founded on 23 July 2002.

Who are the directors of DOKTER FRANCESKA DEDEURWAERDERE?

According to the 2025 annual accounts, the directors of DOKTER FRANCESKA DEDEURWAERDERE are: Franceska Dedeurwaerdere.

Is DOKTER FRANCESKA DEDEURWAERDERE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 23 July 2002; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DOKTER FRANCESKA DEDEURWAERDERE make in 2025?

DOKTER FRANCESKA DEDEURWAERDERE posted a profit after taxes of € 246,302 in financial year 2025.

What is the revenue of DOKTER FRANCESKA DEDEURWAERDERE?

As a small company, DOKTER FRANCESKA DEDEURWAERDERE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 353,337.

DOKTER FRANCESKA DEDEURWAERDERE (Private Limited)

Dossier DOKTER FRANCESKA DEDEURWAERDERE, printed on 20 September 2026 from databakkes.be/en/0477979673/dokter-franceska-dedeurwaerdere. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DOKTER FRANCESKA DEDEURWAERDERE from Ingelmunster, company number BE0477979673, closed financial year 2025 with a result of € 246,302 after tax. For that financial year DOKTER FRANCESKA DEDEURWAERDERE recorded a gross margin of € 353,337 and equity of € 636,445. Compared with financial year 2024, the result moved from € 162,507 to € 246,302. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 28, 2026.

What it is worth Growing

€ 636,445

▲ 22% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 246,302

▲ 52% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 213,899

▲ 58% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 130,300 paid out

53 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 452

▼ 47% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 2,560

▼ 69% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 63,375

▲ 46% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 144,367 Gross margin 2022: € 144,367 First fiscal year in the series	€ 143,072 Gross margin 2023: € 143,072 ▼ 1% vs 2022 (€ 144,367) Unfavourable step	€ 227,339 Gross margin 2024: € 227,339 ▲ 59% vs 2023 (€ 143,072) Favourable step	€ 353,337 Gross margin 2025: € 353,337 ▲ 55% vs 2024 (€ 227,339) Favourable step	▲ 55%
Profit after taxes	€ 100,113 Profit after taxes 2022: € 100,113 First fiscal year in the series	€ 98,679 Profit after taxes 2023: € 98,679 ▼ 1% vs 2022 (€ 100,113) Unfavourable step	€ 162,507 Profit after taxes 2024: € 162,507 ▲ 65% vs 2023 (€ 98,679) Favourable step	€ 246,302 Profit after taxes 2025: € 246,302 ▲ 52% vs 2024 (€ 162,507) Favourable step	▲ 52%
Equity	€ 381,056 Equity 2022: € 381,056 First fiscal year in the series	€ 424,735 Equity 2023: € 424,735 ▲ 11% vs 2022 (€ 381,056) Favourable step	€ 520,443 Equity 2024: € 520,443 ▲ 23% vs 2023 (€ 424,735) Favourable step	€ 636,445 Equity 2025: € 636,445 ▲ 22% vs 2024 (€ 520,443) Favourable step	▲ 22%
Total debts	€ 36,471 Total debts 2022: € 36,471 First fiscal year in the series	€ 45,430 Total debts 2023: € 45,430 ▲ 25% vs 2022 (€ 36,471) Unfavourable step	€ 52,235 Total debts 2024: € 52,235 ▲ 15% vs 2023 (€ 45,430) Unfavourable step	€ 66,495 Total debts 2025: € 66,495 ▲ 27% vs 2024 (€ 52,235) Unfavourable step	▲ 27%
Cash	€ 398,056 Cash 2022: € 398,056 First fiscal year in the series	€ 116,090 Cash 2023: € 116,090 ▼ 71% vs 2022 (€ 398,056) Unfavourable step	€ 135,494 Cash 2024: € 135,494 ▲ 17% vs 2023 (€ 116,090) Favourable step	€ 213,899 Cash 2025: € 213,899 ▲ 58% vs 2024 (€ 135,494) Favourable step	▲ 58%
Retained profit	€ 368,656 Retained profit 2022: € 368,656 First fiscal year in the series	€ 412,335 Retained profit 2023: € 412,335 ▲ 12% vs 2022 (€ 368,656) Favourable step	€ 508,043 Retained profit 2024: € 508,043 ▲ 23% vs 2023 (€ 412,335) Favourable step	€ 624,045 Retained profit 2025: € 624,045 ▲ 23% vs 2024 (€ 508,043) Favourable step	▲ 23%
Dividend	€ 23,100 Dividend 2022: € 23,100 First fiscal year in the series	€ 55,000 Dividend 2023: € 55,000 ▲ 138% vs 2022 (€ 23,100) Unchanged	€ 66,800 Dividend 2024: € 66,800 ▲ 21% vs 2023 (€ 55,000) Unchanged	€ 130,300 Dividend 2025: € 130,300 ▲ 95% vs 2024 (€ 66,800) Unchanged	▲ 95%
Balance sheet total	€ 417,527 Balance sheet total 2022: € 417,527 First fiscal year in the series	€ 470,165 Balance sheet total 2023: € 470,165 ▲ 13% vs 2022 (€ 417,527) Unchanged	€ 572,678 Balance sheet total 2024: € 572,678 ▲ 22% vs 2023 (€ 470,165) Unchanged	€ 702,940 Balance sheet total 2025: € 702,940 ▲ 23% vs 2024 (€ 572,678) Unchanged	▲ 23%

Key figures of DOKTER FRANCESKA DEDEURWAERDERE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DOKTER FRANCESKA DEDEURWAERDERE?

What happened at DOKTER FRANCESKA DEDEURWAERDERE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 28, 2026 New annual accounts for financial year 2025: profit of € 246,302 (▲ 52% vs 2024). Source: NBB ↗
Jul 23, 2002 New establishment in Ingelmunster. KBO
Jul 23, 2002 Start of the company according to the CBE. KBO

In short

From € 100,113 profit in 2022 to € 246,302 profit in 2025.

Paid € 260,698 in corporate taxes since 2022.

Best year ever: 2025, with € 246,302 profit.

Paid out € 275,200 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DOKTER FRANCESKA DEDEURWAERDERE? We notify you, reason included.

Follow DOKTER FRANCESKA DEDEURWAERDERE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Franceska Dedeurwaerdere

DOKTER FRANCESKA DEDEURWAERDERE

Pathologie 16.7%

Behind DOKTER FRANCESKA DEDEURWAERDERE is Franceska Dedeurwaerdere. It owns 16.7% of Pathologie itself.

See the full network in the app

Directors

According to the 2025 annual accounts

Franceska Dedeurwaerdere

Director

Also active at: PATHOLOGIE

Establishments

Establishment units

Physical locations of this company

Registered office

Bruggestraat 74 box B

8770 Ingelmunster

2.302.669.538

Bruggestraat 74

8770 Ingelmunster

Active since 23 July 2002

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

PATHOLOGIE same network

€ 757 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0477.979.673

VAT number

BE 0477.979.673

Registered office

Bruggestraat 74 bus B, 8770 Ingelmunster

Names & denominations

DOKTER FRANCESKA DEDEURWAERDERE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

23 July 2002

Peppol

Active · Active since 12 Dec 2025

Activities · NACE

Activiteiten op het gebied van voeding

Overige menselijke gezondheidszorg, n.e.g.

View on CBE Public ↗ Annual accounts (NBB) ↗

DOKTER FRANCESKA DEDEURWAERDERE

Financials

What happened to DOKTER FRANCESKA DEDEURWAERDERE?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions